The Data is Very Strong: Marijuana Plant Extract Stops Cancers From Spreading

The data is very strong and there's no toxicity associated with a compound found in cannabis could halt the spread of many forms of aggressive cancer, scientists say.

The first research to show marijuana's anti-tumor properties was presented at the American Association for Cancer Research meeting in Los Angeles in 2007 demonstrating that THC may activate biological pathways that halt cancer cell division or block development of blood vessels that feed tumors.

It then became a target of synthetic research into THC for drugs such as ImClone System Inc.'s Erbitux and Amgen Inc.'s Vectibix.

Researchers have now found that the compound, called cannabidiol, had the ability to ‘switch off’ the gene responsible for metastasis in an aggressive form of breast cancer. Importantly, this substance does not produce the psychoactive properties of the cannabis plant.

The team from the California Pacific Medical Center, in San Francisco, first spotted its potential five years ago, after it stopped the proliferation of human breast cancer cells in the lab.

Last year they published a study that found a similar effect in mice. Now they say they are on the verge of publishing further animal study results that expand these results further.

Nonpsychoactive cannabinoids, such as cannabidoil, are particularly advantageous to use because they avoid toxicity that is encountered with psychoactive cannabinoids at high doses useful in the method of the present invention. CBD (Cannabidiol), one of the main constituents of the cannabis plant has been proven medically to relieve many diseases including the inhibition of cancer cell growth.

Recent studies have shown it to be an effective atypical anti-psychotic in treating schizophrenia. CBD also interferes with the amount of THC your brain processes, balancing the psychotropic effect of marijuana. That is precisely why the power of raw cannabis is turning heads.

Speaking to the San Francisco Chronicle, study co-leader Dr Sean McAllister, said: ‘The preclinical trial data is very strong, and there’s no toxicity. There’s really a lot or research to move ahead with and to get people excited.’

While he, along with colleague Dr Pierre Desprez acknowledge that they are some way off from turning their finding into a pill, they are already developing human trial models. They hope to eventually test the drug in combination with current chemotherapies.

Professor Desprez had previously found that a protein called ID-1 seemed to play a role in causing breast cancer to spread. Meanwhile Dr McAllister had discovered the cannabidiol had anti-cancer potential.

The pair teamed up to see if they could treat a particularly aggressive form of breast cancer called ‘triple negative.’ This form, which affects 15 per cent of patients, doesn’t have three hormone receptors that the most successful therapies target. Cells from this cancer have high levels of ID-1.

When they exposed cells from this cancer to cannabidiol they were shocked to find the cells not only stopped acting ‘crazy’ but also returned to a healthy normal state.

They discovered that the compound had turned off the overexpression of ID-1, stopping them from travelling to distant tissues.

Other potentially treatable cancers are forms of leukaemia, lung, ovarian and brain cancers, which also have high levels of ID-1.

Dr Desprez has a particular reason for wanting to create a treatment as quickly as possible – his sister was recently diagnosed with aggressive breast cancer at the age of 41.

Her condition is currently receptive to hormone therapies but Professor Desprez fears it could recur in a form that lacks hormone receptors.

He said: ‘I want to be ready for that. There is a deadline.’

Cannabis is a Class B drug that is illegal to have, give away or sell. “If cannabis were discovered in an Amazon rainforests today, people would be clambering to make as much use as they could out of the potential benefits of the plant,” said Donald L. Abrams, MD, Chief of Hematology and Oncology at San Francisco General Hospital and Professor of Medicine at the University California.

Dr. Abrams is widely known for his research on medical cannabis applications. “Unfortunately, it carries with it a long and not so long history of being a persecuted plant,” he added.

Source:

Prevent Disease

http://worldtruth.tv

If you want to help these blog , like and share the facebook page :

http://www.facebook.com/shortcuttingblog

CISPA Godfather Claims Anonymous is after him

If you want this blog to get up with great information: 
Share & Follow us on facebook and be 

updated! http://www.facebook.com/shortcuttingblog

 

 

 

A co-author of the Cyber Intelligence Sharing and Protection Act says the hacktivist group Anonymous threatened him and others members of Congress on account of their support of CISPA.

The cybersecurity act known as CISPA overwhelmingly passed in the United States House of Representatives earlier this month only to ultimately once again stall in the Senate. Citing the same privacy concerns brought up by opponents outside of Washington, lawmakers in the Senate now say they are unlikely to consider the bill, suggesting that for the second time in as many years CISPA will fail to find its way out of Congress.

But even if those privacy woes indeed warranted a negative reaction from US senators, a co-author of CISPA suggests members of Anonymous had something to do with the defeat.

During a recent interview with Washington, DC-based The Hill, Rep. Dutch Ruppersberger (D-Maryland) said Anonymous hacktivists threatened members of Congress and encouraged anti-CISPA activists to attack supporters of the bill that he co-authored with Rep. Mike Rogers (R-Michigan).

"Anonymous was threatening us. Anonymous was telling [others] to shut down people who supported the bill and that kind of thing," Ruppersberger told the paper during an interview published over the weekend.

When CISPA was introduced by Rogers and Ruppersberger for the first time in 2011, public outcry over alleged privacy violations spurred a legion of opponents to protest on the Web and on the streets. Upon the bill’s reintroduction earlier this year, a similar call to arms was made for privacy advocates to stand up and fight against the argumentative cyber act.

CISPA was described by its authors as being able “to provide for the sharing of certain cyber threat intelligence and cyber threat information between the intelligence community and cybersecurity entities,” but its opponents have raised a number of questions about at what cost. Under CISPA, federal agencies — namely the US Department of Homeland Security and the Department of Justice — would intercept and monitor Internet traffic in order to analyze and deter any attempted cyberattacks. Critics have condemned it, however, saying it essentially allows online businesses to escape liability when letting Uncle Sam spy on Internet activity.

The Electronic Frontier Foundation, one of the largest anti-CISPA groups, wrote of the bill, “It is written so broadly that it allows companies to hand over large swaths of personal information to the government with no judicial oversight — effectively creating a ‘cybersecurity’ loophole in all existing privacy laws.”

Citing the growing opposition this time around, Rep. Ruppersberger told the Hill recently that he purposely asked other members of Congress favoring his bill to stay silent on the issue until the last moment possible to avoid an alleged backlash: three days before the act went up for vote in the House, recalls the Hill, the number of co-sponsors of CISPA jumped from two to 36.

"I didn't want to put anybody who was going to support the bill ... to be subjected to those attacks in their districts, and calling and threatening and that type of thing, so we really decided to not get anybody on the bill right away and to educate people right to the end," Ruppersberger said.

What exactly Ruppersberger means by attacks isn’t exactly obvious, but the call-to-arms that occurred leading up to the recent House vote is virtually inescapable. As with last year, members of Anonymous — along with the EFF, American Civil Liberties Union and others — went quite public with their opposition to the bill as it was readied for a congressional vote.

Last Monday more than 200 websites went offline in protest of CISPA, and the website Reddit and Web browser Firefox both informed their users of the legislation with predominantly displayed messages.

On their part, one message circulated by Anonymous and viewed over 22,000 times appears void of any actual threat, and instead asks opponents to voice their opinion about the bill using a viral Internet campaign. “Anonymous has asked numerous companies to participate in an Internet blackout on Monday, April 22. But, regardless of what these companies choose to do, individuals like ourselves can still help spread awareness of this threat. Below is a link to an image that promotes the hashtag #StopCISPA on Twitter. Make it your profile image all day Monday. Leave it up as long as you want,” reads the post uploaded to PasteBin and attributed to Anonymous.

“Tweet to #CISPA Reps @Call_Me_Dutch and @RepMikeRogers and tell them you oppose their bill,” reads another highly-read posting. Yet another message, viewed more than 7,000 times in under a week, contained the publically available office phone numbers for every congressman that voted for CISPA, along with information on how to raise objections with members of the Senate.

Since the bills passed in the House, a number of Washington sources have suggested that the Senate will once again let the bill die. Sen. Jay Rockefeller (D-West Virginia) said of CISPA that its "privacy protections are insufficient,” and the ACLU’s Michelle Richardson told US News & World Report that the bill was likely "too controversial” and “too expansive” to be considered by the Senate as is. Meanwhile, though, a report published by RT last week reveals that the federal government has already started to implement similar cybersecurity practices that put select parts of the Internet under the radar of the DHS.

Source:

RT

http://worldtruth.tv

 

If you want this blog to get up with great information: 
Share & Follow us on facebook and be 

updated! http://www.facebook.com/shortcuttingblog

The Vaccine Police State is Knocking

If you want this blog to get up with great information:
Share & Follow us on facebook and be updated! http://www.facebook.com/shortcuttingblog

There are six vaccine bills in each of 30+ states that now either require more vaccines for more people or further restrict our right to refuse them.

The National Vaccine Information Center's Advocacy Portal (http://www.nvicadvocacy.org) lists current vaccine bills throughout the U.S. Right now, it lists from one to six vaccine bills in each of 30+ states. Most of these bills, if passed into law, would further expand an already out-of-control pharmaceutical vaccine agenda that seeks to require more vaccines for more people while further restricting our right to refuse them. Join the Portal NOW to help defend vaccine freedom of choice!

Here's a quick look at the authoritarian agendas being promoted by current bills around the U.S.:

Who Is Trying To Patent Marijuana?

If you want this blog to get up with great information:
Share & Follow us on facebook and be updated! http://www.facebook.com/shortcuttingblog

The secret is out: marijuana is medicine. And not to the surprise of the pharmaceutical industry, who is slowly but surely gaining exclusive rights to the medical properties of this age-old plant.

But wait. How can a company, other than Monsanto, patent a plant? That’s not a serious question, but it brings up a serious point. Patents on marijuana have yet to cover genetic modifications of the plant itself, but rather involve the cannabinoids found in marijuana that are responsible for its medical effects.

Phytocannabinoids in the treatment of cancer (Patent No. US20130059018)

The most recent patent filing on cannabinoids comes from none other than GW Pharmaceuticals – the UK-based company that manufactures Sativex (1). Sativex is an oral spray that contains cannabinoids derived from the cannabis plant itself, specifically THC and CBD. Although Sativex is not yet available in the U.S., it has already gained approval in Canada, the UK and eight other European countries.

GW Pharma has been quick to recognize the market potential of cannabis and their most recent patent application makes this more than clear. Just from the title of the patent, one gets a good sense of what GW Pharma has been trying to claim as their own. “Phytocannabinoids” simply means cannabinoids derived from plants, referring to the cannabis plant in this case.

Unsurprisingly, it appears as though GW Pharma encountered difficulties in trying to claim such a broad “invention”. In fact, the updated version of their patent application shows that more than half of their original patent claims were retracted, and for good reason too. Looking back in time, GW Pharma made claims to just the use of isolated cannabinoids in the treatment of cancer, which is no more of an invention than it is a theft from individuals who first proclaimed marijuana’s cancer-fighting abilities decades ago.

On the other hand, GW Pharma’s remaining claims might just pass through the Patent Office without further questioning. GW Pharma seems to be familiar with the pharmaceutical industry’s shrewd patent strategies, which involves modifying pre-existing compounds that have already been proven to work.

In this case, all GW Pharma had to do was claim that they invented a cannabis-based botanical drug substance for treating cancer – botanical drug substance meaning any form of marijuana prepared by methods as simple as aqueous or ethanolic extraction. There you have it. GW Pharma invented neither cannabis nor a method of extraction, but still consider themselves to be inventors of “phytocannabinoids in the treatment of cancer”.

Why Gluten is Bad For you and your Children

If you want this blog to get up with great information:
Share & Follow us on facebook and be updated! http://www.facebook.com/shortcuttingblog

If you have not read my previous article titled "200 Clinically Confirmed Reasons Not To Eat It"  you can click and read it.

Gluten is a protein molecule commonly found in grains like rye, wheat, and barley. It is found in almost every variety of bread, cereal, or grain. Most types of bread contain this protein. People who prefer to avoid gluten fall in two categories–either they’re allergic (this is known as Celiac disease) or because they believe it will lead to health problems. Problem is that so many people are allergic against gluten and they don´t even know it!
This is why we as The Rawfoodfamily have excluded gluten from our diet all together.
The easiest way to avoid the protein is to not eat foods that contain it, or to eat very little of them.